原发性肝癌合并眼眶转移一例
Hepatocellular Carcinoma Metastatic to the Orbit—Report of a Case
DOI: 10.12677/ACM.2020.108274, PDF,   
作者: 季元红*, 吴少兵：盐城市第二人民医院放疗科，江苏 盐城
关键词: 肝癌；眼眶转移；调强放疗；阿帕替尼；Hepatocellula； Orbital Metastasis； Intensity-Modulated Radiation Therapy； Apatinib
摘要: 本个案报道系原发性肝癌合并眼眶转移，采用调强放射治疗联合阿帕替尼靶向治疗，治疗效果达部分缓解，毒副反应小，患者耐受性好。
Abstract: This case report is primary liver cancer with orbital metastasis. Intensity modulated radiation therapy combined with apatinib targeting therapy was used. The treatment effect was partially relieved, with little side effects and good tolerance.
文章引用：季元红, 吴少兵. 原发性肝癌合并眼眶转移一例[J]. 临床医学进展, 2020, 10(8): 1822-1826. https://doi.org/10.12677/ACM.2020.108274

参考文献

[1] 李华雄, 王绿化, 高黎, 等. 肿瘤放射治疗学[M]. 第5版. 北京: 中国协和医科大学出版社, 2018: 1182-1202.
[2] 翁志成, 彭建扬, 吴伟达, 等. 阿帕替尼联合S-TACE治疗中晚期原发性肝癌的疗效及安全性评价[J]. 癌症进展, 2019, 17(22): 2666-2669.
[3] 吴江平, 傅继弟, 张天明, 等. 眼眶转移癌18例临床分析[J]. 中华神经外科疾病研究杂志, 2013, 12(6): 531-534.
[4] 黑砚, 康莉, 李月月, 等. 22例眼眶转移癌临床病理分析[J]. 眼科, 2007, 16(6): 403-406.
[5] 张悦, 鲁保平, 张玉峰, 等. 肝癌眼眶转移病例报告及体会[J]. 中国民康医学, 2015, 27(8): 128-129.
[6] Goldberg, R.A. and Rootman, J. (1990) Clinical Characteristics of Metastatic Orbital Tumors. Ophthalmology, 97, 620-624. [Google Scholar] [CrossRef] 
[7] 王卓, 潘振宇, 张玉宇, 等. 原发性肝细胞癌合并颅眶组织受侵一例[J]. 中华肿瘤杂志, 2016, 38(10): 730-731.
[8] Piccirillo, M., Grunata, V., Albino, V., et al. (2013) Can Hepatocellular Carcinoma (HCC) Produce Unconventional Metastanses? Four case of Extrahepatic HCC. Tumori, 99, e19-e23. [Google Scholar] [CrossRef] [PubMed]
[9] 潘振宇, 曲丽梅, 董丽华, 等. 肝细胞脑膜转移一例[J]. 中华肿瘤杂志, 2014, 36(9): 701-702.
[10] 吴中耀, 主编. 现代眼肿瘤眼眶病学[M]. 北京: 人民军医出版社, 2002: 405-406.
[11] Quick, A.M., Bloomston, M., Kim, E.Y., et al. (2009) Complete Response to Radiation Therapy of Orbital Metastasis from Hepatocellular Caricinoma. World Journal of Gastroenterology, 15, 6000-6003. [Google Scholar] [CrossRef] [PubMed]
[12] Park, Y.J., Lim, D.H., Paik, S.W., et al. (2006) Radiation Therapy for Abdominal Lymph Node Metastasis from Hepatocellular Caricinoma. Journal of Gastroenterology, 41, 1099-1106. [Google Scholar] [CrossRef] [PubMed]
[13] Qin, S.K., Ouyang, X.N., Bai, Y.X, et al. (2014) Multicenter Phase II Study of Apatinib, a Novel Inhibitor of VEGFR, in Patients with Advanced Hepatocellular Carcinoma. ASCO Annual Meeting 2014, Chicago.
[14] 王俊镔, 张晶, 卢冬彦, 等. 阿帕替尼联合经导管肝动脉灌注化疗栓塞治疗中晚期肝癌临床研究的系统评价[J]. 安徽医药, 2019, 23(12): 2504-2510.
[15] 沈锐潮, 卢浩, 熊共鹏. 阿帕替尼联合TACE治疗中晚期肝癌患者临床分析[J]. 医学现代与实践, 2009, 32(23): 3831-3833.

为你推荐